ACUTE CYCLOSPORINE-A NEPHROTOXICITY IN A RENAL-ALLOGRAFT RECIPIENT WITH HYPOTHYROIDISM

被引:12
作者
LEONG, SO
LYE, WC
TAN, CC
LEE, EJC
机构
[1] Department of Medicine, National University Hospital
关键词
CYCLOSPORINE A; KIDNEY; NEPHROTOXICITY; CYTOCHROME P-450 ENZYMES; METABOLISM;
D O I
10.1016/0272-6386(95)90117-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cyclosporine A (CsA) is an important immunosuppressant in kidney transplantation. Acute CsA nephrotoxicity secondary to high drug levels is a well-recognized complication in the immediate posttransplant period, Cyclosporine A is metabolized in the body by the hepatic cytochrome P-450 enzyme system, We present a case of a hypothyroid patient who developed toxic blood CsA levels acid acute nephrotoxicity with standard doses of CsA, A reduction of CsA levels led to an improvement of allograft function, Correction of the hypothyroid state resulted in the normalization of CsA requirements, but overcorrection led to an increased requirement of CsA, Thyroid dysfunction should be considered as an interacting factor in the metabolism of CsA. (C) 1995 by the National Kidney Foundation, Inc.
引用
收藏
页码:503 / 505
页数:3
相关论文
共 14 条
[1]  
CROOKS J, 1973, BRIT J PHARMACOL, V49, pP156
[2]  
EICHELBAUM M, 1976, Clinical Pharmacokinetics, V1, P339, DOI 10.2165/00003088-197601050-00002
[3]   INFLUENCE OF THYROID STATUS ON PLASMA HALF-LIFE OF ANTIPYRINE IN MAN [J].
EICHELBAUM, M ;
BODEM, G ;
GUGLER, R ;
SCHNEIDE.C ;
DENGLER, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 290 (19) :1040-1042
[4]   CYCLOSPORINE-INDUCED ACUTE RENAL DYSFUNCTION IN THE RAT - EVIDENCE OF ARTERIOLAR VASOCONSTRICTION WITH PRESERVATION OF TUBULAR FUNCTION [J].
ENGLISH, J ;
EVAN, A ;
HOUGHTON, DC ;
BENNETT, WM .
TRANSPLANTATION, 1987, 44 (01) :135-141
[5]   PLASMA PROPRANOLOL STEADY-STATE CONCENTRATIONS IN THYROID-DISORDERS [J].
FEELY, J ;
CROOKS, J ;
STEVENSON, IH .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (05) :329-333
[6]  
FEELY J, 1978, CLIN PHARMACOL THER, V23, P112
[7]  
KAHAN BD, 1989, NEW ENGL J MED, V321, P1725
[9]   CLINICAL PHARMACOKINETICS AND ENDOCRINE DISORDERS - THERAPEUTIC IMPLICATIONS [J].
OCONNOR, P ;
FEELY, J .
CLINICAL PHARMACOKINETICS, 1987, 13 (06) :345-364
[10]  
RAM PA, 1992, J BIOL CHEM, V267, P3294